1. Plasma biomarkers, including p-tau217, were found to accurately detect cerebral changes pathognomonic for Alzheimer’s disease in this cross-sectional, multicenter ...
1. In this randomized controlled trial, among 457 participants with prodromal to mild Alzheimer’s disease, semorinemab was not shown to ...
1. In this randomized controlled trial, among 457 participants with prodromal to mild Alzheimer’s disease, semorinemab was not shown to ...
1. APOE ε3 (V236E) and APOE ε4 (R251G), 2 rare missense genetic variants, both had a substantial association with reducing ...
1. This systematic review and meta-analysis demonstrated that the onset of Alzheimer disease in people with Down syndrome is as ...
1. Select features distinguish early-onset Lewy Body Dementia from early-onset Alzheimer dementia, including: hallucinations, slowness, apathy and motor deterioration. 2. ...
1. Physical activity was significantly associated with a decreased incidence of all-cause dementia and Alzheimer’s disease, irrespective of follow-up length, ...
1. Certain sleep phenotypes, such as those with the familial natural short sleepers (FNSS) mutation, anecdotally do not exhibit the ...
1. There were no differences in the risk of Alzheimer disease and related dementia in patients with rheumatoid arthritis treated ...
1. Greater number of neurons in the lateral hypothalamic area (LHA) and tuberomammillary nucleus (TMN) were correlated with decreased sleep ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.